top of page

OUR TEAM

A team of seasoned experts, both in diabetes and in life sciences ventures

FOUNDERS

French MD & Bio-medical Engineer & research scientist

Former Head of Engineering Dept AP-HP Paris

 

Serial successful entrepreneur

 

Private practice as clinical diabetologist

GSK
INSERM
APHP

Pr. Charles-Henri Malbert

CSO

ch.png

Dr. Reginald Allouche

CEO

ra.png

Member of the Academy of Medicine

 

MD, DVM, Doctor es-Sciences

Research director at the INRAE of Rennes

Professor of medicine at the University of Adelaide

Author of > 150 publications in the field of vagal relations between the digestive tract and the brain

INRAE
ADELAIDE UN
ACADEMY

SCIENTIFIC COMMITTEE & ADVISORS

AN EXCEPTIONAL SCIENTIFIC COMMITTEE

fronzeo_edited.jpg

Dr. Ralph DeFronzo, MD

Professor of Medicine and Chief of the Diabetes Division & Deputy Director of Texas Diabetes Institute (TDI) 


Member, Department of Cellular and Integrative Physiology.

Founding father of the modern understanding of T2D

jb.jpeg

Dr. John B. Buse

World-renowned endocrinologist

Leads diabetes research at UNC Chapel Hill  Former President (Medicine & Science) of the American Diabetes Association (ADA)

Pioneer of GLP-1 receptor agonists: key investigator on the LEADER trial  ADA honors: Clinical Diabetes Research Award

BOARD MEMBERS & ADVISORS

JB

John Brooks
advisor

JOSLIN
SB

Sophie Baratte
advisor

CELLNOVO
INSULET

KEY ACHIEVEMENTS & NEXT STEPS

2021

PALTECH CREATION

Paltech creation

POC of the Medical Devices

Launch of the preclinical phase 

2022

PRECLINICAL PHASE

Selection of the active ingredient

First positive results on mini Pigs

Launch of Long lasting experiments

BPI Grant : Deeptech 

CAREERS OPPORTUNITY

Join a passionate team and contribute to a major innovation in the field of diabetes. 
Send us your application

INGÉNIEUR BIOMEDICAL

Paris, France

Take on exciting technical challenges and help create a revolutionary treatment

bottom of page